Patents by Inventor Michael Haka

Michael Haka has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20240277875
    Abstract: The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a ph of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/ml ethanol; and 5-10 mg/ml sodium chloride.
    Type: Application
    Filed: February 7, 2024
    Publication date: August 22, 2024
    Applicants: Blue Earth Diagnostics Limited, Siemens Medical Solutions USA, Inc.
    Inventors: Romain BEJOT, Michael HAKA, Atilio ANZELLOTTI
  • Pharmaceutical formulations
    Patent number: 12036290
    Abstract: The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: July 16, 2024
    Assignees: Blue Earth Diagnostics Limited, Siemens Medical Solutions USA, Inc.
    Inventors: Romain Bejot, Michael Haka, Atilio Anzellotti
  • PHARMACEUTICAL FORMULATIONS
    Publication number: 20210322581
    Abstract: The present invention relates to a pharmaceutical composition comprising a radiohybrid agent containing a silicon-fluoride and a chelating group wherein either the fluorine is 18F or the chelating group contains a chelated radioactive metal, wherein the composition has a pH of 4.0-6.0 and further comprises: 0.1-200 mM citrate buffer; 1-100 mg/mL ethanol; and 5-10 mg/mL sodium chloride.
    Type: Application
    Filed: April 9, 2021
    Publication date: October 21, 2021
    Inventors: Romain Bejot, Michael Haka, Atilio Anzellotti